Cellemedy pursues continuous growth and enhancement
with the next generation immunotherapy in the world.
Commercialization of the Next Generation
Immunotherapy through R&D.
Quantum Jump in Cancer Therapy
by Smart Nano-medicine
Diagnosis · Prevention · Care
World-wide Leader in
Cellemedy develops innovative treatment
of cancer for better health for human world-wide.
Cellemedy’s R&D focuses on Immune Checkpoint Inhibitors
and Vaccines based on Human Ferritin Platform.
Our management team and R&D team are second to none
in their expertise and experience world-wide.
We aim to be the leading immunotherapy provider world-wide
with invention and innovation.